Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites

Toxicology and Applied Pharmacology

Volumn 172, Issue 3, 2001, Pages 249-261

  Kitchin, Kirk T ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Carcinogenesis; Dimethylarsinic acid; K6 ODC transgenic mice; Monomethylarsonic acid; P53+ mice

Indexed keywords

ARSENIC; CACODYLIC ACID; DRINKING WATER; METHANEARSONIC ACID; PROTEIN P53;

ANIMAL MODEL; BLADDER CANCER; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; DOSE RESPONSE; EXPERIMENTAL MODEL; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MOUSE; NONHUMAN; OXIDATIVE STRESS; REVIEW; SKIN CANCER; THYROID CANCER; TOXICOKINETICS; TRANSGENIC MOUSE; WATER CONTAMINATION;

ANIMALIA; MUS MUSCULUS;

EID: 0035341195     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2001.9157     Document Type: Review

References (78)

1. Arsenic: Health effects, mechanisms of actions and research issues
2. Arsenic species that cause release of iron from ferritin and generation of activated oxygen
3. Effects of dietary dimethylarseinic acid on the urine and urothelium of rats
4. Biochemical toxicology of arsenic
5. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic
6. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid(MMA(III)), excreted in human urine
7. Chromosome aberrations in workers exposed to arsenic
8. Expression of p53 in arsenic-related and sporadic basal cell carcinoma
9. Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase activity in rat liver: Relevance to arsenic carcinogenesis
10. Dimethylarsinic acid treatment alters six different rat biochemical parameters: Relevance to arsenic carcinogenesis
11. Infrequent p53 mutations in arsenic-related skin lesions
12. K6/ODC transgenic mice as a sensitive model for carcinogen identification
13. cDNA sequence, protein structure, and chromosomal location of the human gene for poly (ADP-ribose) polymerase
14. Interspecies differences in response to chemical carcinogens
15. Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats
16. Determination of trivalent methylated arsenic species in water, cultured rat hepatocytes, and human urine
17. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors
18. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors
19. Cytogenic effects in human exposure to arsenic
20. Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei
21. Arsenic disrupts cellular levels of p53 and mdm2: A potential mechanism of carcinogenesis
22. The hallmarks of cancer
23. Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice
24. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan
25. Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition on DNA repair enzmes
26. Sequences of Escherichia coti uvrA gene and the protein reveal two potential ATP binding sites
27. The Saccharomyces cerevisiae RAD18 gene encodes a protein that contains potential zinc finger domains for nucleic acid binding and a putative nucleotide binding sequence
28. H DNA amplification in Leishmania resistant to both arsenite and methotrexate
29. A concise review of the toxicology and carcinogenicity of dimethylarsinic acid
30. Predictive assay for rodent carcinogenicity using in vivo biochemical parameters: Operational characteristics and complementarity
31. An integrated pharmacokinetic and pharmacodynamic study of arsenite action. 1. Heme oxygenase induction in rats
32. Speciation of key arsenic metabolic intemediates in human urine
33. Induction of gene amplification by arsenic
34. Nickel chloride inhibits the DNA repair of UV-treated but not methyl methanesulfonate-treated Chinese hamster ovary cells
35. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea
36. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase
37. Acute arsenic-induced free radical production and oxidative stress-related gene expression in mice
38. Methylated arsenic(III) species react directly with DNA and are potential proximate or ultimate genotoxic forms of arsenic
39. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: A model for a mechanism of carcinogenesis
40. The role of oxidative DNA damage in human arsenic carcinogenesis: Detection of 8-hydroxy-2′-deoxyguanosine in arsenic-related Bowen's disease
41. Carcinogenesis modeling: From molecular biology to epidemiology
42. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice
43. Mechanisms of toxicity
44. Is genotoxic effect of arsenic mediated by oxygen free radicals?
45. Occupational and environmental risks in and around a smelter in Northern Sweden. II. Chromosomal abberations in workers exposed to arsenic
46. The induction of ornithine decarboxylase as an early possibly obligatory event in mouse skin carcinogenesis
47. Effects of arsenic cell metabolism and cell proliferation: Cytogenetic and biochemical studies
48. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes
49. +/- male mice
50. Ornithine decarboxylase: A key regulatory enzyme in normal and neoplastic growth
51. Induction of p53 protein expression by sodium arsenite
52. Carcinogenicity of dimethylarsinic acid (DMAA) in p53 knockout and wild type C57BL/6T mice
53. Monomethylarsonic acid reductase and monomethyarsonous acid in hamster tissue
54. Mechanisms of arsenic carcinogenicity: Genetic or epigenetic mechanisms?
55. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols
56. Analysis of a human DNA excision repair gene in group A xeroderma pigmentosum and containing a zinc finger domain
57. Species differences in the metabolism of arsenic compounds
58. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes
59. Carcinogenicity of an organic arsenic, dimethylarsenic acid in animals
60. Promotion of rat hepatocarcinogensesis by dimethylarsinic acid as assessed in rat in vivo models: A review
61. Carcinogenicity of an organic arsenical, dimethylarsenic acid and related arsenicals in rat urinary bladder
62. Promoting effects of dimethylarsinic acid of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats
63. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada
64. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats
65. Inhibition of poly(ADP-ribose)polymerase by arsenite
66. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens
67. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical
68. The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice
69. Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenics, promote skin tumorigenesis in mice
70. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline-1-oxide in the lungs of mice
71. Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals
72. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression